Biogen
BIIB
#822
Rank
HK$187.96 B
Marketcap
HK$1,290
Share price
-1.48%
Change (1 day)
-25.79%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total assets

Total assets on the balance sheet as of September 2024 : HK$220.29 Billion

According to Biogen's latest financial reports the company's total assets are HK$220.29 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Biogen - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31HK$209.65 B9.28%
2022-12-31HK$191.84 B3.04%
2021-12-31HK$186.18 B-2.44%
2020-12-31HK$190.85 B-10.02%
2019-12-31HK$212.10 B7.1%
2018-12-31HK$198.03 B7.16%
2017-12-31HK$184.79 B4.17%
2016-12-31HK$177.39 B17.35%
2015-12-31HK$151.17 B36.16%
2014-12-31HK$111.03 B20.7%
2013-12-31HK$91.99 B17.16%
2012-12-31HK$78.52 B11.71%
2011-12-31HK$70.28 B11.61%
2010-12-31HK$62.97 B-5.02%
2009-12-31HK$66.30 B1.2%
2008-12-31HK$65.52 B-2.61%
2007-12-31HK$67.27 B1.14%
2006-12-31HK$66.51 B2.36%
2005-12-31HK$64.98 B-8.76%
2004-12-31HK$71.22 B-3.31%
2003-12-31HK$73.66 B358.63%
2002-12-31HK$16.06 B19.69%
2001-12-31HK$13.42 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
HK$707.11 B 220.99%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$416.87 B 89.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.115 T 406.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.707 T 675.17%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.387 T 529.70%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.63 B-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.082 T 391.27%๐Ÿ‡ซ๐Ÿ‡ท France
HK$82.50 B-62.55%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$46.79 B-78.76%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$43.45 B-80.28%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands